ERRγ Directs and Maintains the Transition to Oxidative Metabolism in the Postnatal Heart

Cell Metabolism

Volumn 6, Issue 1, 2007, Pages 13-24

  Alaynick, William A ^a,b   Kondo, Richard P ^c   Xie, Wen ^d   He, Weimin ^e   Dufour, Catherine R ^f   Downes, Michael ^a   Jonker, Johan W ^a   Giles, Wayne ^c   Naviaux, Robert K ^g   Giguère, Vincent ^f   Evans, Ronald M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DEVBIO; HUMDISEASE

Indexed keywords

CARBOHYDRATE; ESTROGEN RECEPTOR; CELL RECEPTOR; ESRRG PROTEIN, MOUSE; LACTIC ACID DERIVATIVE; SODIUM; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL TISSUE; ARTICLE; BIRTH; CELL NUCLEUS; CONTROLLED STUDY; DEATH; ECG ABNORMALITY; GENE DISRUPTION; GENE EXPRESSION; GENOMICS; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; MITOCHONDRIAL GENETICS; MOLECULAR GENETICS; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; ANIMAL; BLOOD; CARDIOMEGALY; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; ELECTROCARDIOGRAPHY; ELECTRON TRANSPORT; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; HEART MUSCLE CELL; HEART VENTRICLE; MALE; METABOLISM; MITOCHONDRIAL GENE; MOUSE; MOUSE MUTANT; PATCH CLAMP; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; CARDIOMEGALY; CHROMATIN IMMUNOPRECIPITATION; ELECTROCARDIOGRAPHY; ELECTRON TRANSPORT; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, MITOCHONDRIAL; HEART; HEART VENTRICLES; LACTATES; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATCH-CLAMP TECHNIQUES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; SODIUM;

EID: 34347259219     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.06.007     Document Type: Article

References (67)

1. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., Ahmad F., Matsui T., Chin S., Wu P.H., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 1 (2005) 259-271
2. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., and Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc. Natl. Acad. Sci. USA 103 (2006) 10086-10091
3. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4 (1999) 585-595
4. Barry J.B., Laganiere J., and Giguère V. A single nucleotide in an estrogen-related receptor alpha site can dictate mode of binding and peroxisome proliferator-activated receptor gamma coactivator 1alpha activation of target promoters. Mol. Endocrinol. 20 (2006) 302-310
5. Bartelds B., Knoester H., Smid G.B., Takens J., Visser G.H., Penninga L., van der Leij F.R., Beaufort-Krol G.C., Zijlstra W.G., Heymans H.S., and Kuipers J.R. Perinatal changes in myocardial metabolism in lambs. Circulation 102 (2000) 926-931
6. Binas B., Han X.X., Erol E., Luiken J.J., Glatz J.F., Dyck D.J., Motazavi R., Adihetty P.J., Hood D.A., and Bonen A. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E481-E489
7. Birch-Machin M.A., Briggs H.L., Saborido A.A., Bindoff L.A., and Turnbull D.M. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem. Med. Metab. Biol. 51 (1994) 35-42
8. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., and Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 (2006) 789-799
9. Brackett J.C., Sims H.F., Rinaldo P., Shapiro S., Powell C.K., Bennett M.J., and Strauss A.W. Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency. J. Clin. Invest. 95 (1995) 2076-2082
10. Brouillette J., Trepanier-Boulay V., and Fiset C. Effect of androgen deficiency on mouse ventricular repolarization. J. Physiol. 546 (2003) 403-413
11. Busk P.K., Wulf-Andersen L., Strom C.C., Enevoldsen M., Thirstrup K., Haunso S., and Sheikh S.P. Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro. Exp. Cell Res. 286 (2003) 102-114
12. Chien K.R. Molecular Basis of Cardiovascular Disease. Second Edition (2004), Saunders Press, Philadelphia
13. Christoffels V.M., Mommersteeg M.T., Trowe M.O., Prall O.W., de Gier-de Vries C., Soufan A.T., Bussen M., Schuster-Gossler K., Harvey R.P., Moorman A.F., and Kispert A. Formation of the venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18. Circ. Res. 98 (2006) 1555-1563
14. DiMauro S. Mitochondrial encephalomyopathies. In: Rosenberg R.N., Prusiner S.B., DiMauro S., and Barchi R.L. (Eds). The Molecular and Genetic Basis of Neurological Disease (1993), Butterworth-Heinemann, Boston
15. DiMauro S., Lombes A., Nakase H., Mita S., Fabrizi G.M., Tritschler H.J., Bonilla E., Miranda A.F., DeVivo D.C., and Schon E.A. Cytochrome c oxidase deficiency. Pediatr. Res. 28 (1990) 536-541
16. Ding J.H., Xu X., Yang D., Chu P.H., Dalton N.D., Ye Z., Yeakley J.M., Cheng H., Xiao R.P., Ross J., et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J. 23 (2004) 885-896
17. Dubin D. Rapid Interpretation of EKG's. Fourth Edition (1994), Cover Publishing, Tampa, FL, USA
18. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Evans R.M., Blanchette M., and Giguère V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRα and γ. Cell Metab. 5 (2007) 345-356
19. Gavillet B., Rougier J.S., Domenighetti A.A., Behar R., Boixel C., Ruchat P., Lehr H.A., Pedrazzini T., and Abriel H. Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ. Res. 99 (2006) 407-414
20. Giguère V., Yang N., Segui P., and Evans R.M. Identification of a new class of steroid hormone receptors. Nature 331 (1988) 91-94
21. Gilbert-Barness E. Review: Metabolic cardiomyopathy and conduction system defects in children. Ann. Clin. Lab. Sci. 34 (2004) 15-34
22. Harris R.A., Bowker-Kinley M.M., Huang B., and Wu P. Regulation of the activity of the pyruvate dehydrogenase complex. Adv. Enzyme Regul. 42 (2002) 249-259
23. Hsiao A., Ideker T., Olefsky J.M., and Subramaniam S. VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data. Nucleic Acids Res. 33 (2005) W627-W632
24. Huss J.M., and Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ. Res. 95 (2004) 568-578
25. Huss J.M., Kopp R.P., and Kelly D.P. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J. Biol. Chem. 277 (2002) 40265-40274
26. Huss J.M., Imahashi K.-i., Dufour C.R., Weinheimer C.J., Courtois M., Kovacs A., Giguère V., Murphy E., and Kelly D.P. The nuclear receptor ERRα is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 6 (2007) 25-37 this issue
27. Hwang D.M., Dempsey A.A., Lee C.Y., and Liew C.C. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics 66 (2000) 1-14
28. Kamei Y., Ohizumi H., Fujitani Y., Nemoto T., Tanaka T., Takahashi N., Kawada T., Miyoshi M., Ezaki O., and Kakizuka A. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl. Acad. Sci. USA 100 (2003) 12378-12383
29. Katz A.M. Physiology of the Heart. Third Edition (2001), Lippincott Williams & Wilkins, Philadelphia
30. Kondo R.P., Dederko D.A., Teutsch C., Chrast J., Catalucci D., Chien K.R., and Giles W.R. Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J. Physiol. 571 (2006) 131-146
31. Kostin S., Hein S., Arnon E., Scholz D., and Schaper J. The cytoskeleton and related proteins in the human failing heart. Heart Fail. Rev. 5 (2000) 271-280
32. Laganiere J., Tremblay G.B., Dufour C.R., Giroux S., Rousseau F., and Giguère V. A polymorphic autoregulatory hormone response element in the human estrogen-related receptor α (ERRα) promoter dictates peroxisome proliferator-activated receptor gamma coactivator-1α control of ERRα expression. J. Biol. Chem. 279 (2004) 18504-18510
33. Lehman J.J., and Kelly D.P. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin. Exp. Pharmacol. Physiol. 29 (2002) 339-345
34. Lehman J.J., Barger P.M., Kovacs A., Saffitz J.E., Medeiros D.M., and Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 (2000) 847-856
35. LeWinter M.M., Wu Y., Labeit S., and Granzier H. Cardiac titin: structure, functions and role in disease. Clin. Chim. Acta 375 (2007) 1-9
36. Lie-Venema H., Gittenberger-de Groot A.C., van Empel L.J., Boot M.J., Kerkdijk H., de Kant E., and DeRuiter M.C. Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos. Circ. Res. 92 (2003) 749-756
37. Lin Q., Schwarz J., Bucana C., and Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276 (1997) 1404-1407
38. Lo A.S., Liew C.T., Ngai S.M., Tsui S.K., Fung K.P., Lee C.Y., and Waye M.M. Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1). J. Cell. Biochem. 94 (2005) 763-773
39. Lopaschuk G.D. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure. Semin. Cardiothorac. Vasc. Anesth. 10 (2006) 228-230
40. Luo J., Sladek R., Bader J.A., Matthyssen A., Rossant J., and Giguère V. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature 388 (1997) 778-782
41. Luo J., Sladek R., Carrier J., Bader J.A., Richard D., and Giguère V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol. Cell. Biol. 23 (2003) 7947-7956
42. MacLellan W.R., Xiao G., Abdellatif M., and Schneider M.D. A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol. Cell. Biol. 20 (2000) 8903-8915
43. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
44. Marban E. Cardiac channelopathies. Nature 415 (2002) 213-218
45. Maxwell M.A., and Muscat G.E. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal. 4 (2006) e002
46. Mootha V.K., Handschin C., Arlow D., Xie X., St Pierre J., Sihag S., Yang W., Altshuler D., Puigserver P., Patterson N., et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. USA 101 (2004) 6570-6575
47. Mora A., Davies A.M., Bertrand L., Sharif I., Budas G.R., Jovanovic S., Mouton V., Kahn C.R., Lucocq J.M., Gray G.A., et al. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J. 22 (2003) 4666-4676
48. Morita H., Seidman J., and Seidman C.E. Genetic causes of human heart failure. J. Clin. Invest. 115 (2005) 518-526
49. Nerbonne J.M., and Kass R.S. Molecular physiology of cardiac repolarization. Physiol. Rev. 85 (2005) 1205-1253
50. Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., and Seidman C.E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105 (2002) 446-451
51. Nouette-Gaulain K., Malgat M., Rocher C., Savineau J.P., Marthan R., Mazat J.P., and Sztark F. Time course of differential mitochondrial energy metabolism adaptation to chronic hypoxia in right and left ventricles. Cardiovasc. Res. 66 (2005) 132-140
52. Nuss H.B., and Marban E. Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture. J. Physiol. 479 (1994) 265-279
53. Pashmforoush M., Pomies P., Peterson K.L., Kubalak S., Ross Jr. J., Hefti A., Aebi U., Beckerle M.C., and Chien K.R. Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat. Med. 7 (2001) 591-597
54. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., Mannens M.M., Wilde A.A., and Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 91 (2002) e21-e26
55. Robinson B.H. Lactic acidemia and mitochondrial disease. Mol. Genet. Metab. 89 (2006) 1-2 3-13
56. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., and Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278 (2003) 9013-9018
57. Shepherd D., and Garland P.B. Citrate synthase from rat liver. Methods Enzymol. 13 (1973) 11-16
58. Smeitink J., and van den Heuvel L. Human mitochondrial complex I in health and disease. Am. J. Hum. Genet. 64 (1999) 1505-1510
59. Smeitink J.A., Zeviani M., Turnbull D.M., and Jacobs H.T. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 3 (2006) 9-13
60. Stennard F.A., Costa M.W., Lai D., Biben C., Furtado M.B., Solloway M.J., McCulley D.J., Leimena C., Preis J.I., Dunwoodie S.L., et al. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132 (2005) 2451-2462
61. Sucov H.M., Dyson E., Gumeringer C.L., Price J., Chien K.R., and Evans R.M. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8 (1994) 1007-1018
62. Taylor R.W., and Turnbull D.M. Laboratory diagnosis of mitochondrial disease. In: Applegarth D.A., Dimmick J.E., and Hall J.G. (Eds). Organelle Diseases: Clinical Features, Diagnosis, Pathogenesis, and Management (1997), Chapman & Hall Medical, London 341-350
63. Thum T., and Borlak J. Gene expression in distinct regions of the heart. Lancet 355 (2000) 979-983
64. Willy P.J., Murray I.R., Qian J., Busch B.B., Stevens Jr. W.C., Martin R., Mohan R., Zhou S., Ordentlich P., Wei P., et al. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl. Acad. Sci. USA 101 (2004) 8912-8917
65. Woo Y.J., Panlilio C.M., Cheng R.K., Liao G.P., Atluri P., Hsu V.M., Cohen J.E., and Chaudhry H.W. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 114 1 Suppl (2006) I206-I213
66. Xie W., Hong H., Yang N.N., Lin R.J., Simon C.M., Stallcup M.R., and Evans R.M. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol. 13 (1999) 2151-2162
67. Zhang Y., Ma K., Sadana P., Chowdhury F., Gaillard S., Wang F., McDonnell D.P., Unterman T.G., Elam M.B., and Park E.A. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J. Biol. Chem. 281 (2006) 39897-39906